New drugs unveiled to stop or slow Alzheimer’s disease

New drugs unveiled to stop or slow Alzheimer’s disease

-Written by Ella Scott

Promising details of drugs that could be the first to slow the progression of Alzheimer’s disease have been unveiled overnight.

Data from pharmaceutical company Eli Lily suggests that if given to patients early enough, its solanezumab drug can cut the rate of cognitive decline by almost a third.

Meanwhile interim results from a safety study of another drug, Biogen Inc’s aduncanmab, show reduced amounts of the amyloid plaques in the brain, with an increasing effect as the dose increases.

Currently the death of brain cells in Alzheimer’s patients is unstoppable but solanezumab shows signs of keeping them alive.

The results presented to the Alzheimer’s Association International Conference in Washington, D.C. have been met with cautious optimism.

A new trial is set to report next year and should provide definitive evidence.

Director of research and development at the British Alzheimer’s Society, Dr Doug Brown said the findings “strongly suggest” that targeting people in the earliest stages of Alzheimer’s disease with these antibody treatments is the best way to slow or stop Alzheimer’s disease.

“After a decade of no new therapies for dementia, today’s new is an exciting step forward” he said.

Dr Brown said once ongoing trials finish, the full risks and benefits of the drugs will be known.

Eli Lily’s solanezumab has been the great hope of dementia research for some time, but an 18 month trial of the drug in 2012 ended in failure.

When results of the trail were looked at more closely, however, there was evidence the drug may have been working for patients in the earliest stages of the disease.

It appeared to slow progression of the disease by around 34% during the study.

The company asked more than 1,000 of its patients from the original trial to continue taking the drug for a further two years.

The results were positive, but further trial results next year confirm whether solanezumab is the breakthrough everyone hopes it could be.

About author

Amy Whittaker
Amy Whittaker 1402 posts

Amy joined the NRN team in August 2011, before graduating from a B of Arts (Communication-Journalism)/B of Sports Studies from Charles Sturt University in December 2011.

View all posts by this author →

You might also like

Obama calls for calm in Egypt, cancels joint training exercise

US President Barack Obama says normal relations can not exist with Egypt, in light of the bloody crackdown by the military.

3 women found alive in the US, 10 years after they went missing

A bizarre case has emerged from the US this morning, where three women, believed to have been abducted 10 years ago, have been found alive.


MH17 black box found, bodies removed from site

Pro-Russian rebels say they have found the black box of flight MH17


Greek parliament narrowly passes new austerity measures

Greek parliament has narrowly approved controversial austerity measures, as part of conditions of a new international bailout deal. Earlier this week the Greek Prime Minister Alexis Tsipras agreed to reforms